Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paturi Rao"'
Autor:
GR Sridhar, Paturi Rao
Publikováno v:
RSSDI Textbook of Diabetes Mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::761361374bbc97f524a4d135fa451ef0
https://doi.org/10.5005/jp/books/12626_86
https://doi.org/10.5005/jp/books/12626_86
Autor:
BB Tripathy, Paturi Rao
Publikováno v:
RSSDI Textbook of Diabetes Mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a55d888b91edd8fa94f6293a87c31c29
https://doi.org/10.5005/jp/books/12626_7
https://doi.org/10.5005/jp/books/12626_7
Publikováno v:
RSSDI Textbook of Diabetes Mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6556ffcb96a7c1dd500f4104c9432671
https://doi.org/10.5005/jp/books/12626_10
https://doi.org/10.5005/jp/books/12626_10
Autor:
Paturi Rao, SV Madhu
Publikováno v:
RSSDI Textbook of Diabetes Mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aadd881e609b6a871cba1a49ee292bb0
https://doi.org/10.5005/jp/books/12626_12
https://doi.org/10.5005/jp/books/12626_12
Publikováno v:
RSSDI Textbook of Diabetes Mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47040ab34ef61c3af79aceb3871189ed
https://doi.org/10.5005/jp/books/12626_8
https://doi.org/10.5005/jp/books/12626_8
Autor:
Radhakrishna Sothiratnam, Sultan Linjawi, Paturi Rao, Line Conradsen Hiort, Ramazan Sari, Henning F. Andersen
Publikováno v:
Linjawi, S, Sothiratnam, R, Sari, R, Andersen, H, Hiort, L C & Rao, P 2015, ' The study of once-and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin-The Sit2Mix trial ', Primary care diabetes, vol. 9, no. 5, pp. 370-6 . https://doi.org/10.1016/j.pcd.2014.11.001
AIMS: Investigate efficacy and tolerability of intensifying diabetes treatment with once- or twice-daily biphasic insulin aspart 30 (BIAsp 30) added to sitagliptin, and twice-daily BIAsp 30 without sitagliptin in patients with type 2 diabetes (T2D) i